IDiyas

For the Inventor, By the Inventor

Seoul, South Korea

Kang-Pyo Lee

USPTO Granted Patents = 17 


 

Average Co-Inventor Count = 6.3

ph-index = 4

Forward Citations = 34(Granted Patents)


Company Filing History:

goldMedal17 out of 892 
 
Cj Cheiljedang Corporation
 patents

Years Active: 2008-2023

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents
1. 11759486 - and composition comprising same (2023-09-19),
2. 10842833 - and composition comprising same (2020-11-24),
3. 10130666 - [object Object] (2018-11-20),
4. 10123558 - [object Object] (2018-11-13),
5. 9962418 - Lactobacillus plantarum and composition containing the same (2018-05-08),
6. 9962417 - [object Object] (2018-05-08),
7. 9572846 - [object Object] (2017-02-21),
8. 9572845 - [object Object] (2017-02-21),
9. 9133229 - Economic process for producing xylose from hydrolysate using electrodialysis and direct recovery method (2015-09-15),
10. 9028881 - Composition for preventing and treating hangover (2015-05-12),
11. 8802393 - [object Object] (2014-08-12),
12. 8481720 - Manufacturing method of tagatose using galactose isomerization of high yield (2013-07-09),
13. 8377658 - Process for manufacturing tagatose using soy oligosaccharide (2013-02-19),
14. 8283139 - Method of producing xylitol using hydrolysate containing xylose and arabinose prepared from byproduct of tropical fruit biomass (2012-10-09),
15. 8137946 - Recombinant GRAS strains expressing thermophilic arabinose isomerase as an active form and method of preparing food grade tagatose by using the same (2012-03-20),

Title: Innovations of Kang-Pyo Lee: A Trailblazer in Immunity and Intestinal Health

Introduction

Kang-Pyo Lee is a prominent inventor based in Seoul, South Korea, known for his contributions to the fields of immunology and intestinal health. With a remarkable portfolio comprising 17 patents, he has been a leading figure in developing innovative compositions aimed at treating various health conditions.

Latest Patents

Among his latest innovations, Lee has focused on methods for treating immune diseases that result from a Th1/Th2 imbalance. He has developed a unique approach that includes administering a composition containing the CJLP133 strain KCTC 11403BP. This inventive method aims to restore balance in subjects affected by such immune disorders. Additionally, he has created a composition for treating intestinal diseases utilizing lactic acid bacteria, as well as a composition intended to enhance immunity through these beneficial microorganisms.

Career Highlights

Kang-Pyo Lee's career has been marked by a commitment to advancing health solutions. He is currently affiliated with CJ Cheiljedang Corporation, a leading company in the food and bio industry. Lee's dedication to research and development has made significant impacts, particularly in the areas of immunity and gastrointestinal health.

Collaborations

Throughout his career, Lee has collaborated with esteemed colleagues such as Heon Woong Jung and Bong Joon Kim. These partnerships have fostered an environment of innovation and have contributed to the advancement of various health-related inventions.

Conclusion

Kang-Pyo Lee exemplifies the spirit of innovation in the health sector. His dedication to addressing critical health issues through his inventions and collaborations highlights the importance of ongoing research in the quest for better treatments. With numerous patents to his name, Lee continues to pave the way for future advancements in immunology and intestinal health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…